(Total Views: 679)
Posted On: 10/06/2022 9:37:34 AM
Post# of 154011

It is a mistake not to continue studies involving leronlimab against Covid. There already exists a fairly large body of information concerning something that is not going away anytime soon. https://www.statnews.com/2022/10/06/bq11-omic...ext-phase/

